ciprofloxacin and leucine

ciprofloxacin has been researched along with leucine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's8 (72.73)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Avdeef, A; Tam, KY1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Bellman, K; Knegtel, RM; Settimo, L1
Majtán, V; Majtánová, L1
Dileep, U; Fuller, MF; Kurpad, AV; Raj, T; Vaz, M1
Chew, JW; Hadinoto, K; Teo, J; Yu, H1
Ambrus, R; Csóka, I; Karimi, K; Katona, G1
Bhujbal, S; Mangal, S; Park, H; Shetty, N; Zemlyanov, D; Zhou, QT1
Ahn, P; Bhujbal, S; Cavallaro, A; Li, J; Mangal, S; Park, H; Shetty, N; Zemlyanov, D; Zhou, QT1
Cavallaro, A; Mangal, S; Narang, AS; Nicholas, M; Nour, R; Park, H; Puri, V; Shetty, N; Thalberg, K; Zemlyanov, D; Zhou, QT1
Chen, XD; Chen, Y; Wu, WD; Yan, S; Yin, Q; Zhang, S1

Other Studies

11 other study(ies) available for ciprofloxacin and leucine

ArticleYear
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Postantibiotic effect of some antibiotics on the metabolism of Pseudomonas aeruginosa.
    Journal of basic microbiology, 1998, Volume: 38, Issue:3

    Topics: Adenine; Amikacin; Anti-Bacterial Agents; Carbon Radioisotopes; Cell Division; Ciprofloxacin; Imipenem; Leucine; Meropenem; Nucleic Acid Synthesis Inhibitors; Oxygen Consumption; Pefloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Thienamycins

1998
Intestinal microbial contribution to metabolic leucine input in adult men.
    The Journal of nutrition, 2008, Volume: 138, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Humans; Intestines; Leucine; Male

2008
Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    International journal of pharmaceutics, 2016, Feb-29, Volume: 499, Issue:1-2

    Topics: Aerosols; Anti-Bacterial Agents; Bronchiectasis; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Freeze Drying; Leucine; Mannitol; Nanoparticles; Particle Size; Pseudomonas aeruginosa

2016
Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Journal of pharmaceutical and biomedical analysis, 2018, Jan-30, Volume: 148

    Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Ciprofloxacin; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Leucine; Microscopy, Electron, Scanning; Particle Size; Powders; Surface Properties; X-Ray Diffraction

2018
Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    International journal of pharmaceutics, 2018, Jun-10, Volume: 544, Issue:1

    Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Ciprofloxacin; Desiccation; Disaccharides; Drug Compounding; Drug Stability; Excipients; Humidity; Leucine; Mannitol; Particle Size; Powders

2018
Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Molecular pharmaceutics, 2018, 09-04, Volume: 15, Issue:9

    Topics: Administration, Inhalation; Aerosols; Ciprofloxacin; Colistin; Drug Stability; Drug Synergism; Dry Powder Inhalers; Excipients; Leucine; Particle Size; X-Ray Diffraction

2018
Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.
    International journal of pharmaceutics, 2019, Sep-10, Volume: 568

    Topics: Aerosols; Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Liberation; Dry Powder Inhalers; Excipients; Leucine; Lubricants; Particle Size; Powders; Stearic Acids; Surface Properties

2019
Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation.
    AAPS PharmSciTech, 2022, Aug-02, Volume: 23, Issue:6

    Topics: Administration, Inhalation; Aerosols; Chemistry, Pharmaceutical; Ciprofloxacin; Dry Powder Inhalers; Freeze Drying; Leucine; Particle Size; Powders

2022